GRAM
Gold Flora Corporation0.0001
+0.0000+0%
Dec 16, 4:00:00 PM EST
Earnings Call Transcripts
This Quarter (Q1 '26)
No earnings call transcript available yet
Last Quarter (Q4 '25)
No earnings call transcript available
Key Stats
Market Cap
28.77KP/E (TTM)
-Basic EPS (TTM)
-0.42Dividend Yield
0%Recent Filings
8-K
Receivership triggers board resignations
Gold Flora Corporation entered receivership on March 28, 2025, with Stone Blossom Capital appointed as receiver following its ex parte application. Directors Michael Lau, Heather Molloy, Jeffery Sears resigned April 7; Al Foreman followed April 8. Board gutted. Company warns securities trading is highly speculative, with likely total loss for shareholders in receivership.
8-K
Receivership triggers asset sales
Gold Flora Corporation entered receivership on March 28, 2025, when a California court appointed Stone Blossom Capital as receiver over all assets for management, preservation, and court-approved sale to creditors. OTCQB trading halted, shifting to OTC Pink on April 3. Shareholders face substantial risk of total loss.
8-K
Trading suspended, delisting ahead
Gold Flora's common stock and warrants were suspended from Cboe Canada trading on March 28, 2025, following its March 27 receivership filing in California court; OTCQB quotation halted same day. Delisting looms after 150 days with no lift expected. Trading remains highly speculative. Shareholders face significant or total loss risk in receivership.
8-K
Files for receivership over debt
Gold Flora filed for voluntary receivership in California court on March 27, 2025, expecting Richard Ormand as receiver to sell its assets—including 16 dispensaries and 100,000 sq ft cultivation—to pay creditors amid $11.5 million in defaulted notes to J.J. Astor. Legacy lawsuits from TPCO acquisition and high debt crushed liquidity, yet operations continue as a going concern. Equity holders face total wipeout risk.
8-K
Closes $2M loan draw
Gold Flora issued a second additional note on December 31, 2024, under its Loan Agreement with J.J. Astor & Co., securing $1,920,000 funding against $2,780,000 principal repayable in 40 weekly installments starting October 6, 2025. It brings total draws to $11.15 million from the $13.15 million facility, with one $2 million draw left. Covenants restrict debt and stock moves. Default triggers 110% principal and conversion option.
ACB
Aurora Cannabis Inc.
5.53+0.41
CBDW
1606 CORP.
0.00+0.00
CRLBF
Cresco Labs Inc.
1.75+0.45
FLGC
Flora Growth Corp.
8.84+0.39
GRLF
Green Leaf Innovations, Inc.
0.00+0.00
GRUSF
Grown Rogue International Inc.
0.44+0.03
GTBIF
Green Thumb Industries Inc.
9.63+1.23
MAJI
Marijuana Inc.
0.05-0.02
PM
Philip Morris International Inc
157.95-0.46
TOBAF
TAAT Global Alternatives Inc.
0.04+0.00